Search Results - "Pechan, Peter"
-
1
Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule
Published in Molecular therapy (01-02-2011)“…Inhibition of vascular endothelial growth factor (VEGF) for the management of the pathological ocular neovascularization associated with diseases such as…”
Get full text
Journal Article -
2
Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo
Published in Cancer research (Chicago, Ill.) (01-04-2001)“…To evaluate the efficiency of gene delivery in gene therapy strategies for malignant brain tumors, it is important to determine the distribution and magnitude…”
Get full text
Journal Article -
3
Aurintricarboxylic acid increases yield of HSV-1 vectors
Published in Molecular therapy. Methods & clinical development (01-01-2014)“…Production of large quantities of viral vectors is crucial for the success of gene therapy in the clinic. There is a need for higher titers of herpes simplex…”
Get full text
Journal Article -
4
Generation of an Adenovirus Vector Lacking E1, E2a, E3, and All of E4 except Open Reading Frame 3
Published in Journal of Virology (01-07-1999)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
5
Intraarterial delivery of adenovirus vectors and liposome-DNA complexes to experimental brain neoplasms
Published in Human gene therapy (20-01-1999)“…This study investigated the intraarterial delivery of genetically engineered replication-deficient adenovirus vectors (AVs) and cationic liposome-plasmid DNA…”
Get more information
Journal Article -
6
Detailed Protocol for the Novel and Scalable Viral Vector Upstream Process for AAV Gene Therapy Manufacturing
Published in Human gene therapy (01-08-2021)“…Recombinant adeno-associated viral (rAAV) vector-based gene therapy has been adapted for use in more than 100 clinical trials. This is mainly because of its…”
Get more information
Journal Article -
7
Free radicals induce gene expression of NGF and bFGF in rat astrocyte culture
Published in Neuroreport (01-06-1992)“…Hydrogen peroxide (H2O2) is a type of active oxygen species produced mainly in blood by inflammation, ischemia or anoxia. Treatment of rat neonatal cortical…”
Get more information
Journal Article -
8
Gene Therapies for Neovascular Age-Related Macular Degeneration
Published in Cold Spring Harbor perspectives in medicine (01-07-2015)“…Pathological neovascularization is a key component of the neovascular form (also known as the wet form) of age-related macular degeneration (AMD) and…”
Get full text
Journal Article -
9
Genetically modified fibroblasts producing NGF protect hippocampal neurons after ischemia in the rat
Published in Neuroreport (1995)“…The neuroprotective effect of nerve growth factor (NGF) on the pyramidal cells in the vulnerable CA1-CA2 sectors of the hippocampus was investigated in a rat…”
Get more information
Journal Article -
10
HSV-1 infected cell proteins influence tetracycline-regulated transgene expression
Published in The journal of gene medicine (01-09-2000)“…Background This study investigates elements of herpes simplex virus type 1 (HSV‐1) which influence transgene expression in tetracycline‐regulated expression…”
Get full text
Journal Article -
11
Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas
Published in The journal of gene medicine (01-05-1999)“…Background The versatility of HSV‐1 vectors includes large transgene capacity, selective replication of mutants in dividing cells, and availability of…”
Get full text
Journal Article -
12
bFGF induces its own gene expression in astrocytic and hippocampal cell cultures
Published in Neuroreport (01-12-1992)“…Basic FGF mRNA induction by bFGF was investigated in cell cultures from rat brain, i.e. postnatal day 2 cortex and embryonic day 18 hippocampus. In situ…”
Get more information
Journal Article -
13
Inhibition of pathological brain angiogenesis through systemic delivery of AAV vector expressing soluble FLT1
Published in Gene therapy (01-11-2015)“…The soluble vascular endothelial growth factor (VEGF) receptor 1 (sFLT1) has been tested in both animals and humans for anti-angiogenic therapies, for example,…”
Get full text
Journal Article -
14
sFLT01: a novel fusion protein with antiangiogenic activity
Published in Molecular cancer therapeutics (01-03-2011)“…sFLT01 is a novel fusion protein that consists of the VEGF/PlGF (placental growth factor) binding domain of human VEGFR1/Flt-1 (hVEGFR1) fused to the Fc…”
Get full text
Journal Article -
15
AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2−/− /Cx3cr1−/− mice
Published in Neurobiology of aging (01-02-2012)“…Abstract To test the effects of adeno-associated virus encoding sFLT01 (AAV5.sFLT01) on the retinal lesions in Ccl2 −/− /Cx3cr1 −/− mice, a model for…”
Get full text
Journal Article -
16
AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2 super(-/-)/Cx3cr1 super(-/-) mice
Published in Neurobiology of aging (01-02-2012)“…To test the effects of adeno-associated virus encoding sFLT01 (AAV5.sFLT01) on the retinal lesions in Ccl2 super(-/-)/Cx3cr1 super(-/-) mice, a model for…”
Get full text
Journal Article -
17
AAV‐mediated sFLT‐1 gene therapy ameliorates retinal lesions in Ccl2/Cx3cr1 deficient mice
Published in The FASEB journal (01-04-2010)“…To test the effect of subretinal delivery of adeno‐associated virus (AAV)‐sFLT‐1 (soluble VEGF receptor‐1) on retinal lesion in ccl2−/−/cx3cr1−/− mice, a…”
Get full text
Journal Article -
18
Abstract A14: sFLT01: An antiangiogenic protein that neutralizes placental growth factor
Published in Molecular cancer therapeutics (10-12-2009)“…Abstract Introduction: Anti-angiogenic agents have shown clinical value in combination with chemotherapy by targeting the VEGF pathways. The development of…”
Get full text
Journal Article -
19
HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells
Published in Human gene therapy (10-02-1997)“…Novel hybrid vectors, which incorporate critical elements of both herpes simplex virus type 1 (HSV-1) amplicon vectors and adeno-associated virus (AAV)…”
Get more information
Journal Article -
20
503. A Novel Herpes Simplex Virus Helper Based Production of Adeno-Associated Virus Vectors for Treatment of Retinal Angiogenesis
Published in Molecular therapy (01-05-2006)“…AGTC's proprietary rAAV vector production method uses recombinant herpes simplex virus (HSV) as the helper agent for rAAV production. This production method…”
Get full text
Journal Article